| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Sphingolipid metabolism integrated pathway 0.8019381798041809 2.8633893194895 0.0041913521791898 0.9205555140915094 0.3158180620680754 10 O95470,Q16739,Q96G23,P27544,Q06136,Q13510,O15269 7 |
| Sphingolipid metabolism overview 0.8019381798041809 2.8633893194895 0.0041913521791898 0.9205555140915094 0.3158180620680754 10 O95470,Q16739,Q96G23,P27544,Q06136,Q13510,O15269 7 |
| Mitochondrial complex iv assembly 0.796772079544851 2.837177902606645 0.0045514243885127 0.9361215764884449 0.3158180620680754 10 P13073,P20674,O43819,P14406 4 |
| Sphingolipid pathway 0.7829996566322639 2.836116004713548 0.0045665855813437 0.9367055546166696 0.3158180620680754 11 P04062,O95470,Q16739,Q9Y5P4,Q96G23,Q06136,Q13510,O15269 8 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6058008334774789 2.759976669501345 0.0057805489501274 0.9696750525263612 0.3158180620680754 23 O60488,P37268,O75845,Q14739,Q15392,Q16850,Q15800,Q9BWD1,Q9UBM7 9 |
| Sphingolipid metabolism in senescence 0.6790518646580773 2.5107901448156382 0.0120461284039232 0.9993297906342984 0.3158180620680754 14 P04062,P16278,Q16739,Q96G23,Q06136,Q13510,O15269 7 |
| Ferroptosis 0.5457417232454 2.3748942401581106 0.0175539790479604 0.9999769779011708 0.4182333363166182 25 O60488,P37268,Q15043,P09601,Q9Y277,P45880 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.8688922610015188 2.2917575496971674 0.0219196374940655 0.9999984301893786 0.4875920377163029 5 Q16739,Q10472,Q06136,O95470 4 |
| Oxidation by cytochrome p450 0.8237781662132656 2.211159511012619 0.0270247930869307 0.999999933108702 0.4902893139488656 6 Q6UW02,O43169,Q16850,Q9UHQ9 4 |
| Electron transport chain oxphos system in mitochondria 0.4749274422429096 2.1758812336394544 0.0295641423922623 0.9999999861642818 0.4902893139488656 45 Q9UDW1,P24539,P14406,P13073,P03886,P20674,O75964 7 |
| Cholesterol biosynthesis pathway 0.6240445216794535 2.1075307095637887 0.0350716026321245 0.9999999995527628 0.4902893139488656 13 P37268,O75845,Q16850,Q15800,Q9UBM7 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7927124597073374 2.073582702208367 0.0381180830594547 0.9999999999335611 0.4902893139488656 6 Q16850,O75845,Q9UBM7,Q15392 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5889816540054652 2.0448501589259664 0.0408696329281272 0.9999999999881908 0.4902893139488656 15 P50402,O75844,P42167,O60725 4 |
| Metapathway biotransformation phase i and ii 0.5320539739333432 1.9955869003482796 0.0459789065677409 0.9999999999995284 0.4902893139488656 20 Q6UW02,Q8NCH0,Q16850,P07099 4 |
| Mitochondrial complex iii assembly 0.6547477274192647 1.9362278811681684 0.0528397971265675 0.999999999999994 0.5139096397954871 9 Q9UDW1,Q6DKK2 2 |
| Influence of laminopathies on wnt signaling 0.6207101536764305 1.8913178803299655 0.058581923268528 1.0 0.5194838195723886 10 P50402,O75844,O60725 3 |
| Statin inhibition of cholesterol production 0.7626469651578627 1.8319747327000164 0.0669551851699723 1.0 0.5646239463727603 5 P37268 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8183953634240735 1.811631714007584 0.070043121247044 1.0 0.5646239463727603 4 O60725,P02545 2 |
| Striated muscle contraction pathway 0.8182466019997621 1.81100812527412 0.0701395939240829 1.0 0.5646239463727603 4 P67936,P08670 2 |
| Progeriaassociated lipodystrophy 0.6314940827530546 1.8104446594340176 0.0702268590015871 1.0 0.5646239463727603 9 O60725,O75844,P02545 3 |
| Burn wound healing 0.6560664159088019 1.7094679811341895 0.087364297814277 1.0 0.6567061394678698 8 P09429,P08670 2 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.7119115221330576 1.7063825187760606 0.087936883203703 1.0 0.6567061394678698 6 P35240,P27348,P05556 3 |
| Glycosaminoglycan degradation 0.7328054417561267 1.6990841867134316 0.089303322448367 1.0 0.6567061394678698 5 P06865,P16278 2 |
| Allograft rejection 0.5816190060571611 1.667409556346637 0.0954329949417696 1.0 0.670268887489767 10 P13747,P08183,Q9BY49,P08670 4 |
| Familial partial lipodystrophy fpld 0.6892091909829925 1.6666003244066552 0.0955939043517744 1.0 0.670268887489767 7 O60725,O75844,P02545 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7009060239675382 1.6553975169050483 0.0978438893632185 1.0 0.6704530146138724 6 P09601 1 |
| Kennedy pathway from sphingolipids 0.7202107095893886 1.6425622300245792 0.1004735407948482 1.0 0.6807364617898147 5 P49585,P35790 2 |
| Vitamin a and carotenoid metabolism 0.7665525247227861 1.5925171733597971 0.1112685475085957 1.0 0.7025072296701914 4 P28482,Q8WTV0 2 |
| Nonalcoholic fatty liver disease 0.4177392189414791 1.592231647279737 0.1113326647878594 1.0 0.7025072296701914 48 Q9UDW1,P09669,P14406,P49327,P54646,P13073,O75251,Q9P0J0,P00403,P49840,P31040,P31751,O96000,Q86Y39,P22695,Q9Y6M9,P08574,O95168,P20674 19 |
| Degradation pathway of sphingolipids including diseases 0.6835994803246982 1.574806904209293 0.1153010222908494 1.0 0.7094542494018595 6 P06865,P06280,P16278 3 |
| Translation factors 0.398614863265943 1.516552058145776 0.1293798173955493 1.0 0.7465679193876175 36 O15372,P20042,Q15056,O75153,Q13347,O75822,Q9NR50 7 |
| Cellular proteostasis 0.7481796116504853 1.514104297246543 0.1299993889480926 1.0 0.7465679193876175 4 O15212,Q9UHV9,P61758 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.7351334951456322 1.4582339174943209 0.1447760778779103 1.0 0.7820223974298462 4 O00170,P07900,Q15185 3 |
| Amyotrophic lateral sclerosis als 0.5674336881323344 1.4564056914228134 0.1452805031537285 1.0 0.7820223974298462 9 P07197,Q9UER7,Q08209,P07196 4 |
| Spinal cord injury 0.4656789378346144 1.4518749032234686 0.1465363919401658 1.0 0.7820223974298462 19 P28482,P08670,Q9NQC3,Q08209,O75116,P14174 6 |
| Endothelin pathways 0.5589526368805842 1.408827879167691 0.1588860693159266 1.0 0.7820223974298462 9 P28482,Q05682,P00403,P16615,P42892 5 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5061735161896664 1.3790354391319293 0.1678838275153624 1.0 0.7820223974298462 13 O15372,O75822,P20042 3 |
| Relationship between inflammation cox2 and egfr 0.7090412621359203 1.3461296929284856 0.1782606941466411 1.0 0.7820223974298462 4 P28482,P27361,P31751 3 |
| 7oxoc and 7betahc pathways 0.5245043938186055 1.3327191890239345 0.1826239736499548 1.0 0.7820223974298462 10 Q86TX2,O15118 2 |
| Proteoglycan biosynthesis 0.6312583213660263 1.3285055943022814 0.1840111366932073 1.0 0.7820223974298462 6 Q8NCH0,Q8TB61 2 |
| Pregnane x receptor pathway 0.641099745143094 1.2829805929638332 0.1994988753269055 1.0 0.8019854788141604 5 P08183,P07900,O15439 3 |
| Proteasome degradation 0.3770067316916321 1.2551687271501988 0.209417515518939 1.0 0.8259460289141074 40 P13747,P28070,P10321,P49721,P62191,O43242,P28074 7 |
| Il7 signaling pathway 0.6147540983606452 1.250275362383448 0.2111989752696019 1.0 0.8259460289141074 6 Q02750,P28482,P40763,P49841,P27361 5 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.5075648576748624 1.2321980939450523 0.2178750951520773 1.0 0.8259460289141074 10 P37268 1 |
| Ccl18 signaling pathway 0.5271249692128102 1.229255431383166 0.2189760517712788 1.0 0.8259460289141074 9 Q86UE4,P00403,P08670,P07196 4 |
| Ketogenesis and ketolysis 0.6249556840975876 1.209016306801026 0.2266565806161162 1.0 0.8384902951626878 5 O43772 1 |
| Preimplantation embryo 0.591085559189751 1.1905258295176615 0.2338397841453439 1.0 0.8563624405393547 7 Q92945 1 |
| Glycerolipids and glycerophospholipids 0.6019057959324128 1.18928374148562 0.2343280309933557 1.0 0.8563624405393547 6 Q9HCL2 1 |
| Zinc homeostasis 0.8414190418435419 1.162826987747139 0.244899705150257 1.0 0.8825647107393264 2 Q15043 1 |
| Vitamin d receptor pathway 0.4869815032555608 1.1489378060090538 0.2505816270362668 1.0 0.8888277711933465 11 P08183 1 |
| Mevalonate pathway 0.609410858453393 1.1377841292542232 0.2552106336290618 1.0 0.8960058805961914 5 Q9BWD1 1 |
| Il5 signaling pathway 0.4776576302973422 1.1342006188026796 0.2567104045227122 1.0 0.8960058805961914 12 Q15418,Q02750,P28482,P49840,P49841 5 |
| Nanoparticlemediated activation of receptor signaling 0.5898911366923547 1.132228138572429 0.2575385330010098 1.0 0.8960058805961914 6 P28482,P05556 2 |
| Proximal tubule transport 0.4867690465300787 1.108408751528532 0.2676853270602159 1.0 0.922367155527487 10 P04920,P08183 2 |
| Methionine de novo and salvage pathway 0.5379501593551614 1.0949834049142253 0.2735239068856923 1.0 0.9268887478133756 8 Q13126 1 |
| Nephrotic syndrome 0.4440585469054215 1.0893257792058637 0.2760102484929598 1.0 0.9268887478133756 15 O75844,Q14108,P02545 3 |
| Acetylcholine synthesis 0.8231725811343694 1.0878004557411305 0.2766832083025001 1.0 0.9268887478133756 3 P49585,P35790 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.448352690942407 1.0611473634622537 0.2886229360413237 1.0 0.9363156521405362 14 O60488,P40939,O43772,Q16836,Q9BY49,Q96CM8 6 |
| Endometrial cancer 0.4685028731129744 1.036242932121911 0.3000888223809133 1.0 0.9363156521405362 11 Q02750,P31751,P28482,P35222,Q13418,P49841 6 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4677707722743852 1.03177962697493 0.3021753653142964 1.0 0.9363156521405362 11 Q8TB36,Q15907,Q9NR77,P20338 4 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.5230925450551092 1.0169041828038334 0.3091990133326581 1.0 0.9363156521405362 8 P28482,Q15418,P27361,Q02750 4 |
| Nanomaterial induced apoptosis 0.5646240097300312 1.0124018131063894 0.3113459718054987 1.0 0.9363156521405362 6 Q9NR28 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4137374391665215 0.9714919623858372 0.3313033537027987 1.0 0.9410731622109328 17 P50402,O94901,P42167,Q14739 4 |
| Angiopoietinlike protein 8 regulatory pathway 0.3579720968210643 0.9706637619826088 0.331715742957591 1.0 0.9410731622109328 32 P41440,Q15418,Q9UPT5,Q02750,P31751,O75955,Q01518,O00767,P28482,P49327,P54646,P49840,P49841,P27361 14 |
| Urea cycle and related diseases 0.7907822922983634 0.9626337572088028 0.335731350609467 1.0 0.9410731622109328 2 Q9UJS0 1 |
| Tryptophan metabolism 0.4313266342128787 0.9489695826480332 0.3426360825905399 1.0 0.9410731622109328 14 P40939,P51648 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.6143810679611652 0.9397540516668502 0.3473437326350825 1.0 0.9410731622109328 4 P35222,P27361,P40763 3 |
| Tgfbeta receptor signaling 0.6143810679611652 0.9397540516668502 0.3473437326350825 1.0 0.9410731622109328 4 P35222,P27361,P40763 3 |
| Vitamin d metabolism 0.7794965119805976 0.9254793119580064 0.3547166400777732 1.0 0.9410731622109328 3 P04062,Q9UBM7 2 |
| Hippoyap signaling pathway 0.7798665858095823 0.920218409178106 0.3574586360431757 1.0 0.9410731622109328 2 P27348 1 |
| Histone modifications 0.468641366650288 0.8981793648797736 0.3690899326896497 1.0 0.9410731622109328 9 Q01105,P84243,Q03164 3 |
| Estrogen receptor pathway 0.771805532646677 0.8972677132102768 0.3695760805612291 1.0 0.9410731622109328 3 Q9HCL2 1 |
| Physicochemical features and toxicityassociated pathways 0.4209948807121997 0.8810964537612983 0.3782656164981863 1.0 0.9410731622109328 14 Q02750,P07737,P07196,P07197,P28482,O75116,P49841 7 |
| Phase i biotransformations non p450 0.7603329320139829 0.8554510523368215 0.3923014910741664 1.0 0.9410731622109328 3 Q15165 1 |
| Camkk2 pathway 0.4438865312192456 0.8537170705616971 0.3932617733720251 1.0 0.9410731622109328 10 P28482,P09601 2 |
| Liver x receptor pathway 0.7622801697998793 0.8526346216944054 0.3938619568138519 1.0 0.9410731622109328 2 O00767 1 |
| 16p112 distal deletion syndrome 0.4569895877473412 0.832755676757413 0.404982536811036 1.0 0.9429247544968856 9 Q8WWM7,Q9H2V7 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.3552756068714405 0.8322003779510936 0.4052958505874753 1.0 0.9429247544968856 27 P04406,Q04917,P12235,P40939,P04075,P62258,P10644,P27348,P61981,P63104,P50416,P42892,Q9H0U9,P14625 14 |
| Type 2 papillary renal cell carcinoma 0.5172592117171979 0.8299485252894799 0.4065678875110949 1.0 0.9429247544968856 7 Q15369,Q92733 2 |
| T cell receptor and costimulatory signaling 0.5116937976760179 0.8031178943070497 0.4219065958644989 1.0 0.950637191072298 7 P49840 1 |
| Omega3 omega6 fatty acid synthesis 0.5198199767333886 0.8020821870378056 0.4225054182543546 1.0 0.950637191072298 6 O15254,O60488,Q15067 3 |
| Omega9 fatty acid synthesis 0.5102886886137254 0.758019832783654 0.4484391098692797 1.0 0.99050836355742 6 P49327,O60488,O00767 3 |
| Glucocorticoid receptor pathway 0.5091947305198403 0.7529838848345968 0.4514595979813132 1.0 0.99354064811216 6 P27105,P07900,Q15185 3 |
| Map3k1 role in promoting and blocking gonadal determination 0.5214085735349033 0.7400643380541464 0.4592609563065872 1.0 1.0 5 P28482,P49841,P35222 3 |
| Phosphodiesterases in neuronal function 0.7237719830200131 0.7087619136997948 0.478472236311964 1.0 1.0 2 O43924 1 |
| Hedgehog signaling pathway wp47 0.721952698605216 0.702132566031589 0.4825964947531611 1.0 1.0 2 O00422 1 |
| Copper homeostasis 0.4605031563633166 0.6923342587250614 0.4887274405199955 1.0 1.0 8 O43819,P35670 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3250977096841557 0.6863562807938636 0.4924884665016209 1.0 1.0 33 Q16850,P37268,Q9HCL2,P49840 4 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.71064604185624 0.6791001020414121 0.4970744378283052 1.0 1.0 3 P28482,Q02750 2 |
| Serotonin receptor 467 and nr3c signaling 0.71064604185624 0.6791001020414121 0.4970744378283052 1.0 1.0 3 P28482,Q02750 2 |
| S1p receptor signal transduction 0.4273914391070304 0.6688990423648519 0.5035598811351454 1.0 1.0 9 Q9NRA0,Q13510 2 |
| Mapk pathway in congenital thyroid cancer 0.7104305639781696 0.6605556948216154 0.5088972900385462 1.0 1.0 2 Q02750 1 |
| Neovascularisation processes 0.7104305639781694 0.6605556948216139 0.5088972900385471 1.0 1.0 2 P28482 1 |
| Pi3kaktmtor vitd3 signaling 0.4965181384645597 0.6319763001024552 0.5274023638195753 1.0 1.0 5 P08559,P54646 2 |
| Ciliary landscape 0.3322402325431502 0.6225130118465508 0.5336045905225859 1.0 1.0 112 Q96PK6,Q7L5N1,P09669,Q9Y266,P60660,Q9BT78,P84243,Q14566,O95400,P16278,Q15555,Q9NQH7,P43034,P08670,Q9NVJ2,Q96P70,P06280,P30084,Q9Y6G9,O95292,P63167,Q9UPT5,Q96RK4,Q8IYI6,P07197,P51665,P49736,Q9Y4W6,P10619,Q96FJ2,P56545,P14649,P07196,P27105,Q92905,O15173 36 |
| Hair follicle development organogenesis part 2 of 3 0.6921024756938765 0.6158455156099762 0.5379964839445139 1.0 1.0 3 P05556 1 |
| Neural crest differentiation 0.4169408322971806 0.6122107509822536 0.5403983294138286 1.0 1.0 9 P56545,P49841,Q9NR77,P05556 4 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4767959020803282 0.6063617012533782 0.5442745945913119 1.0 1.0 6 P28482,Q02750 2 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3813934658399028 0.5855081837280846 0.5582060655016758 1.0 1.0 13 P28482,P08670,P05067 3 |
| Oxysterols derived from cholesterol 0.4119172662073609 0.585246126293675 0.5583822336863893 1.0 1.0 9 Q86TX2 1 |
| Onecarbon metabolism and related pathways 0.3742973284873094 0.579995936083896 0.5619173583423658 1.0 1.0 14 P49585,P35790 2 |
| Mitochondrial immune response to sarscov2 0.4092921261703409 0.5712369767916611 0.5678390161990279 1.0 1.0 9 Q99623,Q9Y6M9,P35232,O94826,Q86UT6 5 |
| Mirna regulation of prostate cancer signaling pathways 0.4308164747381972 0.5443366347786588 0.5862098413666639 1.0 1.0 8 P28482,P49841,Q02750 3 |
| Sarscov2 b117 variant antagonises innate immune activation 0.6746513038204984 0.5366074092278089 0.5915388251067544 1.0 1.0 2 O94826 1 |
| Epo receptor signaling 0.449133977121301 0.510936901509128 0.6093952407018728 1.0 1.0 7 P28482,P27361,Q02750,P40763 4 |
| Bile acids synthesis and enterohepatic circulation 0.6599581706918756 0.5105717748137422 0.6096509440689466 1.0 1.0 3 P28482 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5031727951139982 0.490452012279856 0.6238140791923092 1.0 1.0 4 P08670 1 |
| Selenium micronutrient network 0.3724347887009993 0.4903764689965578 0.6238675246346457 1.0 1.0 12 Q9NVS9 1 |
| Tp53 network 0.6555488174651316 0.4742063970460322 0.6353527320645469 1.0 1.0 2 Q13315 1 |
| Il18 signaling pathway 0.3121538916331535 0.4317893413810371 0.6658945269071439 1.0 1.0 57 P40939,P62280,P28482,Q13011,Q07866,Q9NZJ7,P16949,P09601,Q92733,P45974,Q8N6T3,P35613,Q9UMR5 13 |
| Regulatory circuits of the stat3 signaling pathway 0.4279222050979558 0.4180330967592249 0.6759229191017417 1.0 1.0 7 P16949 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6269335759781733 0.4095271244596589 0.6821528653142848 1.0 1.0 3 P28482,P27361 2 |
| Mitochondrial complex ii assembly 0.6315949060036399 0.4003768164538143 0.6888789972046037 1.0 1.0 2 P31040 1 |
| Familial hyperlipidemia type 4 0.6297756215888429 0.3949888490114885 0.6928511174827869 1.0 1.0 2 P49327 1 |
| Gpr40 pathway 0.6267434808975149 0.386081375990095 0.6994364023765458 1.0 1.0 2 P29992 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6184410069760508 0.3849090979416763 0.7003047650851384 1.0 1.0 3 P28482,P27361 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.417668299178778 0.3747518333842498 0.7078450392813083 1.0 1.0 7 O43683 1 |
| Immune response to tuberculosis 0.6141947224749784 0.3728291668692617 0.7092755934192807 1.0 1.0 3 O75925,Q03518 2 |
| Mammary gland development pathway involution stage 4 of 4 0.6182534869617964 0.3616334019529855 0.7176260005443549 1.0 1.0 2 P04637 1 |
| Sars coronavirus and innate immunity 0.6140084899939371 0.3496889071345797 0.7265721795452993 1.0 1.0 2 Q7Z434 1 |
| Complement system in neuronal development and plasticity 0.3466245788842506 0.3460038455640568 0.729339824697695 1.0 1.0 12 Q9NR28 1 |
| Oxidative phosphorylation 0.293258537909645 0.3299114292739044 0.7414668872571355 1.0 1.0 29 P24539,O96000,Q86Y39,Q9Y6M9,P03886,O75964 6 |
| Pdgf pathway 0.3425107717668511 0.3239829279623349 0.745950959255371 1.0 1.0 12 Q02750,P28482,P40763,P00403,P53365,P19174,P27361 7 |
| Steroid biosynthesis 0.6030927835051559 0.3198615628504673 0.7490732766888115 1.0 1.0 2 Q99829 1 |
| Il9 signaling pathway 0.4026555247822838 0.31364157685637 0.753793277981988 1.0 1.0 7 P28482,P27361,Q02750,P40763 4 |
| Nad metabolism sirtuins and aging 0.4493325242718394 0.3041468101680035 0.7610160456286139 1.0 1.0 4 P43490,Q00059,P09874 3 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3557768133005587 0.3025247971540559 0.7622520330992832 1.0 1.0 9 Q86UE4,P49841,P56545,P67870 4 |
| Glycogen synthesis and degradation 0.3185504338961529 0.29673793194853 0.7666665951336711 1.0 1.0 16 P52789,P30153,P49840 3 |
| Prolactin signaling pathway 0.3061473405597111 0.2833895840766272 0.7768782119759394 1.0 1.0 19 Q02750,P05556,P28482,P63104,P61981,P49841 6 |
| Myometrial relaxation and contraction pathways 0.3061282526867516 0.283265847353027 0.7769730554092076 1.0 1.0 19 Q04917,Q05682,P27348,P62258,P10644,P16615,P61981 7 |
| Fatty acid betaoxidation 0.3028091633311503 0.279947175856142 0.7795180325360265 1.0 1.0 20 P40939 1 |
| Leptininsulin signaling overlap 0.5867192237719845 0.2776220752837273 0.7813024844211829 1.0 1.0 2 P40763 1 |
| Prion disease pathway 0.3926315661981185 0.274512630376382 0.7836906986627981 1.0 1.0 7 P28482,Q9UQE7,P14625 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3382296860631452 0.2723701413983032 0.7853374288247745 1.0 1.0 10 P28482,Q02750,P49840,P31751 4 |
| Leukocyteintrinsic hippo pathway functions 0.4342849161601108 0.2580012098780582 0.7964059734814959 1.0 1.0 4 P27348 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.3458747152566802 0.2575107321447322 0.796784531539116 1.0 1.0 9 Q8IXH7 1 |
| Ebola virus infection in host 0.2688634386213312 0.2250636469093671 0.8219297610401182 1.0 1.0 37 P41440,P13747,P05556,P28482,O75569,O15118,P10321,Q99816,Q9UN37,P09496,P42566,O43707 12 |
| Mitochondrial gene expression 0.38097093368212 0.2245097533865865 0.8223606785054707 1.0 1.0 6 Q08209,O00411 2 |
| Adipogenesis 0.3077811389441187 0.2186179949701636 0.8269476339062911 1.0 1.0 15 O75844,P02545 2 |
| Sleep regulation 0.4189927184465977 0.2142572741206941 0.8303464346381033 1.0 1.0 4 Q99808,P00813,P23526 3 |
| Parkinsons disease pathway 0.3354603463992727 0.2122351207331718 0.8319236084069206 1.0 1.0 9 O43464,P22314,Q9Y385,P07814,P68036,P42575,Q99497,Q99700 8 |
| Serine metabolism 0.3746205221615099 0.203435685978326 0.8387945095613636 1.0 1.0 6 P00374,P34896,P34897,Q9Y617,O43175 5 |
| Alzheimers disease 0.3003132617835185 0.1903333198548508 0.849047945386973 1.0 1.0 79 P28070,O95197,P28482,Q07866,P16615,Q9NQC3,Q16186,P49721,Q08209,P62191,O43242,Q9Y277,P05067,P45880,P28074,P21796 16 |
| Inclusion body myositis 0.5392547121131495 0.1885569834580446 0.8504400501600666 1.0 1.0 3 P05067 1 |
| Vegfavegfr2 signaling pathway 0.2265804810214089 0.1844298617252747 0.8536762453349453 1.0 1.0 170 P35613,Q02750,P61254,P07737,P00367,Q15369,Q01105,O75569,P04075,P49257,Q08209,P49327,Q14157,P54646,P06753,P51571,O15372,P55209,P05556,Q4VCS5,P62280,P62258,Q12849,P46777,Q9H2U1,P09429,O14773,O15460,P07900,P30825,O43852,P11171,Q9Y520,P42566,O75116,P20338,Q02543,Q16527,P61421,P28482,Q5VU43,Q6Y7W6,Q9NYL9,Q00059 44 |
| Vasopressinregulated water reabsorption 0.2957267995391048 0.1840331188416887 0.8539874735465611 1.0 1.0 17 Q15907,Q13561,Q9UJW0,Q96FJ2,Q12846,P63167 6 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.5328532303363861 0.1756315996007749 0.8605833753296095 1.0 1.0 3 P49841 1 |
| Glutathione metabolism 0.3655130540376444 0.1744131020431043 0.8615408181909483 1.0 1.0 6 P48637,P00390,O75874,P48506,P48507 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3652966120023441 0.1737411058623612 0.8620689309750444 1.0 1.0 6 P28482,Q02750 2 |
| Apoptosis modulation and signaling 0.2963315516578038 0.1711713245351486 0.86408905440988 1.0 1.0 16 Q9NR28 1 |
| Alzheimers disease and mirna effects 0.2988114418283538 0.1690262279535169 0.8657760112882487 1.0 1.0 81 P28070,O95197,P28482,Q07866,P16615,Q96IX5,Q16186,P49721,Q08209,Q9NQC3,P62191,O43242,Q9Y277,P05067,P45880,P28074,P21796 17 |
| Osteopontin signaling 0.4012142485301463 0.1677124374940896 0.8668095110824474 1.0 1.0 4 P28482,Q02750 2 |
| Rac1pak1p38mmp2 pathway 0.3023441404477091 0.16769367351087 0.8668242735168221 1.0 1.0 14 P28482,P16949,P35222,P05556 4 |
| Development of ureteric collection system 0.3685201314402569 0.1639916525363612 0.8697377151595345 1.0 1.0 5 Q13418,P05556 2 |
| Bdnftrkb signaling 0.3419718900913563 0.1593638048236839 0.8733822539942135 1.0 1.0 8 P28482,Q15418 2 |
| Pentose phosphate pathway in senescent cells 0.3654021244309626 0.1554114587165424 0.8764969511711693 1.0 1.0 5 P37837,P04637,P29401,O95336 4 |
| Pentose phosphate metabolism 0.3654021244309626 0.1554114587165424 0.8764969511711693 1.0 1.0 5 P37837,P29401,P52209,O95336 4 |
| Cysteine and methionine catabolism 0.3571211661099246 0.1486918489026551 0.8817967933694137 1.0 1.0 7 P25325,P48637,P48506,P32929,P17174,P23526 6 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3161790279920838 0.1347156272941306 0.8928367170323372 1.0 1.0 9 P28482,O14964,Q8WUM4,P31943 4 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5130382049727122 0.1283600240511558 0.897864065582374 1.0 1.0 2 P08195 1 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3474656447633704 0.1213404138979281 0.9034214108279404 1.0 1.0 6 P28482,Q02750,P31751 3 |
| Mirnas involved in dna damage response 0.3768203883495025 0.1119157832446821 0.9108901820054438 1.0 1.0 4 P16104,P04637,Q13315 3 |
| Nanoparticle triggered autophagic cell death 0.4900193321861396 0.1015546269820119 0.919110195594374 1.0 1.0 3 Q13111 1 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.3366605392614007 0.0867093964629839 0.9309025072545094 1.0 1.0 7 P84243 1 |
| Photodynamic therapyinduced hif1 survival signaling 0.3189343389325724 0.0823429088452492 0.9343740339271168 1.0 1.0 8 P53985 1 |
| Nephrogenesis 0.463311097634932 0.066376196637336 0.9470783207329794 1.0 1.0 2 O95747 1 |
| Osx and mirnas in tooth development 0.463311097634932 0.066376196637336 0.9470783207329794 1.0 1.0 2 P35222 1 |
| Canonical and noncanonical notch signaling 0.4633110976349318 0.0663761966373358 0.9470783207329796 1.0 1.0 2 P55081 1 |
| Hepatocyte growth factor receptor signaling 0.296560177913283 0.0653294264193093 0.9479117134876625 1.0 1.0 9 P28482,Q02750,P05556 3 |
| Nad metabolism 0.449196239005154 0.050886548654 0.959415924242314 1.0 1.0 3 P43490,P09874 2 |
| Ras and bradykinin pathways in covid19 0.4449989289738414 0.0467224161849043 0.9627344643214424 1.0 1.0 3 P28482 1 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.3349514563106717 0.0388689647998517 0.9689948603639966 1.0 1.0 4 P28482,P21333,P27361 3 |
| Nuclear receptors metapathway 0.2603968120864406 0.0313894327722203 0.9749589684262814 1.0 1.0 49 O00767,Q99735,P49327,Q15185,P06493,P52209,O15439,P07900,O00170,P09601,Q9H2J7,P30043,P08238,P08183,Q9HCL2,Q15043,Q15067,Q86UP2,P27105,Q16543,P50416,P48507 22 |
| Urea cycle and metabolism of amino groups 0.300425273390042 0.0294727100878696 0.9764875836785324 1.0 1.0 8 P32322,P78540,P12277,P00367,P19623,P04181,P54886 7 |
| Interactome of polycomb repressive complex 2 prc2 0.3088648892790931 0.0293148466385739 0.9766134860860848 1.0 1.0 6 Q9Y2W1 1 |
| Ciliopathies 0.2533669133660151 0.0221786573395083 0.9823054423790644 1.0 1.0 25 Q96RK4,Q15555,Q9NQH7,O43924,Q8WXW3,Q7Z4L5,Q10713,Q8NFG4,Q13432 9 |
| Genes related to primary cilium development based on crispr 0.2634431107367095 0.0205491522453961 0.9836053025190152 1.0 1.0 17 Q96RK4,O95684,Q8WXW3,Q7Z4L5,P63167 5 |
| Aspirin and mirnas 0.3611279563371758 0.0144126772215456 0.9885007454807532 1.0 1.0 2 O15439 1 |
| Notch signaling 0.298421372191868 0.0096559296171263 0.992295802557828 1.0 1.0 6 Q92542,Q04721,P56545,Q92769,Q13547 5 |
| Methylation pathways 0.388838337882923 0.0071674143063024 0.9942812797476844 1.0 1.0 3 Q9NZL9,P21964 2 |
| Fatty acid transporters 0.2928679817905958 0.0067825772699278 0.9945883278064164 1.0 1.0 5 Q9UKU0,O60488,P33121,Q6P1M0 4 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.2768155575812835 0.0062106340795878 0.995044662811312 1.0 1.0 9 Q9Y478,P05556,P08069,Q13418,P06730,P49841,Q15118,P49770 8 |
| Interactions between loxl4 and oxidative stress pathway 0.3033980582524143 0.002157915678743 0.9982782337326794 1.0 1.0 4 Q96EB6,Q8TAG9,Q16543 3 |
| Mitochondrial complex i assembly model oxphos system 0.2498077757188926 0.0012717593921133 0.9989852830895058 1.0 1.0 24 Q9P0J0,O96000,Q96CU9,Q9Y6M9,Q9BUB7,P03886 6 |
|
|
